|
Name |
Tetratriacontane
|
| Molecular Formula | C34H70 | |
| IUPAC Name* |
tetratriacontane
|
|
| SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
| InChI |
InChI=1S/C34H70/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-34H2,1-2H3
|
|
| InChIKey |
GWVDBZWVFGFBCN-UHFFFAOYSA-N
|
|
| Synonyms |
Tetratriacontane; N-TETRATRIACONTANE; 14167-59-0; 94UA0738YX; NSC-2998; n-Tetratriacontane 100 microg/mL in Hexane; Tetratriacontane, analytical standard; UNII-94UA0738YX; NSC 2998; EINECS 238-013-0; Tetratriacontane, 98%; AI3-36492; DTXSID7058622; CHEBI:87443; NSC2998; ZINC6920424; BBL103832; LMFA11000587; MFCD00009412; STL557642; AKOS025212369; AS-57006; DB-042580; CS-0315160; FT-0637022; T0687; T2938; T71761; Q151145; J-007535; FF7BB6B8-4684-449E-9BAA-3CEDC172E786
|
|
| CAS | 14167-59-0 | |
| PubChem CID | 26519 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 478.9 | ALogp: | 18.0 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 31 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
| Heavy Atoms: | 34 | QED Weighted: | 0.069 |
| Caco-2 Permeability: | -5.613 | MDCK Permeability: | 0.00000133 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.031 |
| 30% Bioavailability (F30%): | 1 |
| Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 104.18% |
| Volume Distribution (VD): | 6.065 | Fu: | 0.49% |
| CYP1A2-inhibitor: | 0.017 | CYP1A2-substrate: | 0.104 |
| CYP2C19-inhibitor: | 0.078 | CYP2C19-substrate: | 0.048 |
| CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.984 |
| CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.007 |
| CYP3A4-inhibitor: | 0.095 | CYP3A4-substrate: | 0.006 |
| Clearance (CL): | 4.14 | Half-life (T1/2): | 0.002 |
| hERG Blockers: | 0.543 | Human Hepatotoxicity (H-HT): | 0.002 |
| Drug-inuced Liver Injury (DILI): | 0.525 | AMES Toxicity: | 0.01 |
| Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.06 |
| Skin Sensitization: | 0.986 | Carcinogencity: | 0.01 |
| Eye Corrosion: | 0.998 | Eye Irritation: | 0.922 |
| Respiratory Toxicity: | 0.111 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000438 | ![]() |
0.971 | D00AOJ | ![]() |
0.590 | ||
| ENC000381 | ![]() |
0.940 | D00STJ | ![]() |
0.390 | ||
| ENC000437 | ![]() |
0.910 | D07ILQ | ![]() |
0.368 | ||
| ENC000443 | ![]() |
0.880 | D00FGR | ![]() |
0.367 | ||
| ENC000436 | ![]() |
0.850 | D0Z1QC | ![]() |
0.350 | ||
| ENC000541 | ![]() |
0.847 | D01NTX | ![]() |
0.345 | ||
| ENC000435 | ![]() |
0.820 | D0Z5SM | ![]() |
0.328 | ||
| ENC001705 | ![]() |
0.813 | D06KDP | ![]() |
0.310 | ||
| ENC001204 | ![]() |
0.812 | D05ZPL | ![]() |
0.298 | ||
| ENC000401 | ![]() |
0.790 | D0T9TJ | ![]() |
0.294 | ||